UPDATE: Citi Downgrades Kite Pharma (KITE) to Neutral

March 2, 2017 5:45 AM EST Send to a Friend
(Updated - March 2, 2017 6:12 AM EST)

Citi downgraded Kite Pharma (NASDAQ: KITE) from Buy to Neutral, price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login